Home > Insider Trading > Filing (0000950170-25-023166)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1745999	Beam Therapeutics Inc.	BEAM	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1963878	Christine Bellon	C/O Beam Therapeutics Inc., 238 Main Street Cambridge MA 02142	Chief Legal Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-02-14	9,492	$7.22	112,460	No	4	M	Direct
Common Stock	Acquisiton	2025-02-14	508	$7.22	112,968	No	4	M	Direct
Common Stock	Disposition	2025-02-14	10,000	$34.00	102,968	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2025-02-14	9,492	$0.00	9,492	$7.22
Common Stock	Stock Option (Right to Buy)	Disposition	2025-02-14	508	$0.00	508	$7.22

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2029-05-16	No	4	M	Direct
10,410		2029-05-17	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 20, 2024.
The option vested as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option was fully vested.
The option vested as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option was fully vested.